Cumberland Pharmaceuticals (CPIX) Share-based Compensation (2016 - 2026)
Cumberland Pharmaceuticals' Share-based Compensation history spans 16 years, with the latest figure at $172160.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation rose 130.12% to $172160.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $408320.0, a 35.25% increase, with the full-year FY2025 number at $408320.0, up 35.25% from a year prior.
- Share-based Compensation hit $172160.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $81262.0 in the prior quarter.
- Over the last five years, Share-based Compensation for CPIX hit a ceiling of $224786.0 in Q4 2021 and a floor of -$27753.0 in Q2 2022.
- Historically, Share-based Compensation has averaged $113231.2 across 5 years, with a median of $92025.0 in 2023.
- Biggest five-year swings in Share-based Compensation: tumbled 114.46% in 2022 and later soared 452.68% in 2023.
- Tracing CPIX's Share-based Compensation over 5 years: stood at $224786.0 in 2021, then plummeted by 43.54% to $126905.0 in 2022, then dropped by 26.01% to $93894.0 in 2023, then decreased by 20.32% to $74812.0 in 2024, then soared by 130.12% to $172160.0 in 2025.
- Business Quant data shows Share-based Compensation for CPIX at $172160.0 in Q4 2025, $81262.0 in Q3 2025, and $80686.0 in Q2 2025.